Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates

Authors:

Abstract
Colorectal cancer (CRC) is the third most common cancer and the third leading cause of cancer-related deaths in the United States.1,2 Owing to the relatively slow growth of precancerous colon and rectal lesions, screening is effective for both prevention and early detection of disease and has been demonstrated to reduce mortality.3,4 The US Preventive Services Task Force recommends screening for all individuals from 50 to 75 years of age (grade A), and in May 2021, they updated their recommend screening guidelines to include individuals 45 to 49 years of age (grade B).5-7 Nonetheless, the US screening rate remains well below the national benchmark of 80% as established by the National Colorectal Cancer Roundtable.1,8

This publication has 41 references indexed in Scilit: